These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4829543)

  • 1. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA; Lubawy WC; Kostenbauder HB
    Life Sci; 1974 Apr; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of lynestrenol on the rate of metabolism of phenobarbital, phenytoin and hexobarbital in mice.
    Rümke CL; Noordhoek J
    Eur J Pharmacol; 1969 May; 6(2):163-8. PubMed ID: 5796802
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of diphenylhydantoin on hexobarbital sleep time in mice and rats.
    Kemp JW; Tannhauser M; Swinyard EA
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):37-47. PubMed ID: 5111324
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.
    Robinson JR; Nebert DW
    Mol Pharmacol; 1974 May; 10(3):484-93. PubMed ID: 4852151
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic drug metabolism after phenobarbital and diphenylhydantoin administration in the rat--influence of vitamin D3 status.
    Gascon-Barré M; Côte MG; Brodeur J
    Biochem Pharmacol; 1979; 28(2):313-9. PubMed ID: 218591
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the metabolism of diphenylhydantoin in mice.
    Gerber N; Arnold K
    J Pharmacol Exp Ther; 1969 May; 167(1):77-90. PubMed ID: 5772752
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and environmental factors affecting hexobarbital metabolism in mice.
    Vesell ES
    Ann N Y Acad Sci; 1968 Jul; 151(2):900-12. PubMed ID: 5263697
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B; Alexanderson B; Sjöqvist F
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):299-307. PubMed ID: 4109017
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and spectral studies of type I and type II compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin.
    Stavchansky SA; Kostenbauder HB; Lubawy WC
    Drug Metab Dispos; 1975; 3(6):557-64. PubMed ID: 1233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hexachlorophene, tribromsalan, trichlorcarban and cloflucarban on hexobarbital sleeping time and hepatic drug-metabolizing enzyme activity in vitro in the rat.
    Condie LW; Buhler DR
    Biochem Pharmacol; 1979; 28(3):375-80. PubMed ID: 426854
    [No Abstract]   [Full Text] [Related]  

  • 12. Interference of hepatic drug metabolism in Plasmodium berghei-infected mice and its therapeutic modification: A study of hexobarbital sleeping time and phenobarbital-induced liver stimulation.
    Einheber A; Wren RE; Klobukowski CJ
    Exp Parasitol; 1970 Jun; 27(3):424-43. PubMed ID: 5419453
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of subacute intoxication with some heavy metals on hexobarbital sleep and metabolism.
    Stoytchev T; Krotev L
    Acta Physiol Pharmacol Bulg; 1978; 4(3):29-35. PubMed ID: 751449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexobarbital sleeping time in male rats with hepatic injury.
    Varga F; Fischer E
    Acta Physiol Acad Sci Hung; 1969; 36(4):431-9. PubMed ID: 5376036
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):79-89. PubMed ID: 507999
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D; Broermann I; Honecker H; Kluwe S; Coper H
    Psychopharmacologia; 1972; 27(4):349-57. PubMed ID: 4648618
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanisms of digitoxin potentiation of hexobarbital sleeping time in rats.
    Staneva-Stoicheva D; Tancheva L
    Acta Physiol Pharmacol Bulg; 1978; 4(3):36-42. PubMed ID: 751451
    [No Abstract]   [Full Text] [Related]  

  • 19. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of hexobarbital metabolism by diethylnitrosamine.
    Stevenson IH; Greenwood DT
    Biochem Pharmacol; 1968 May; 17(5):842-5. PubMed ID: 4297005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.